|
Class 2 Device Recall Syva Emit Methotrexate Assay |
![see related information](../images/related-info.gif) |
Date Initiated by Firm |
March 08, 2016 |
Date Posted |
May 06, 2016 |
Recall Status1 |
Terminated 3 on August 07, 2017 |
Recall Number |
Z-1618-2016 |
Recall Event ID |
73594 |
510(K)Number |
K811459
|
Product Classification |
Enzyme immunoassay, methotrexate - Product Code LAO
|
Product |
Syva Emit Methotrexate Assay, is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of methotrexate in human serum or plasma. |
Code Information |
Lot # F1, F2, G1, G2, H1, and H2 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 500 Gbc Dr Ms 514 PO BOX 6101 Newark DE 19702-2466
|
For Additional Information Contact |
Richard Andersen 302-631-0528
|
Manufacturer Reason for Recall |
Siemens Healthcare Diagnostics confirmed that Syva Emit Methotrexate Application (DVMTX.1) for Dimension Vista System does not meet On-Board Stability claim of 20 hours. Testing using reagent at the end of the 20 hours On-Board Stability has shown that values of methotrexate for patient and quality control samples increased.
|
FDA Determined Cause 2 |
Unknown/Undetermined by firm |
Action |
Siemens mailed an Urgent Medical Device Correction letter to customers informing them that they were withdrawing the Emit Methotrexate Application on the Dimension Vista System. Customers were asked to contact their local Siemens sales representative for alternative testing solutions for Methotrexate. Siemens advised customers to change the On-Board Stability for the Methotrexate application on the Dimension Vista System to four hours: alternatively, customers can run the Methotrexate application in batch mode, along with QC. It was also requested in the notification that customers complete and return the Field Correction Effectiveness Check Form that was attached with the notification within 30 days. |
Quantity in Commerce |
18364 units |
Distribution |
Units were shipped to MI, FL, NJ, NY, DC, CA, GA, MI, MT, VA, NC, TX, PA, Australia, Belgium, Czech Republic, Finland, Japan, Republic of Korea, Italy, Saudi Arabia, Slovakia, Slovenia, Spain and Switzerland. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = LAO and Original Applicant = SYVA CO.
|
|
|
|